CorFlow Therapeutics AG Company
![](/files/companies/CorFlow%20Therapeutics%20AG.png)
CorFlow Therapeutics AG is a startup that creates their own technologies to help diagnose and treat microvascular obstructions in heart attack patients. Their technologies can help reduce short- and long-term complications in severe heart attack patients.
Headquarters:
Zug
Estimated Revenue:
Less than $1M
Industry:
Medical Technology